We are harnessing nitric oxide’s proven and broad therapeutic properties, topically

about us

Noxogen Therapeutics is a specialty pharmaceutical company focused on innovating ways to harness the therapeutic properties of nitric oxide (NO) for the non-invasive, topical treatment of systemic and dermatological conditions and their symptoms.

nitric=oxide

Endogenous to the human body

nitric oxide is an essential cellular signalling molecule

with proven vasodilatory, anti-inflammatory and anti-microbial properties.

It was named 1992 Molecule of the Year by the journal, Science

and its discovery as a signalling molecule earned the 1998 Nobel Prize in Medicine.

the challenges

to using nitric oxide topically in therapeutic settings include:

  • its gaseous form
  • its adverse effects in uncontrolled concentrations, even when used topically
  • the chemical instability of nitric oxide donors

noxogen’s
innovation

a patented, easy-to-use formulation that solves the challenges of releasing nitric oxide locally, enabling topical therapies that harness its proven benefits.

A two-component hydrogel
system delivered through an
applicator device

  • Topical delivery

  • Adjustable NO release times

  • Proven NO skin penetration

  • Attractive safety profile that avoids systemic undesirable effects

  • Stable storage

technology
platform

We are leveraging our proprietary technology in both pharmaceutical and medical-aesthetic applications, harnessing nitric oxide’s established vasodilatory and anti-microbial effects

Pharmaceutical applications

(all currently in preclinical phase)

NTX-1001

Neuropathic pain

NTX-1002

Tinea pedis

NTX-1003

Erectile dysfunction

NTX-1004

Wound-healing

Medical-aesthetic applications

(all currently in discovery phase)

NTX-2001

Alopecia

NTX-2002

Anti-ageing

NTX-2003

Anti-microbial cleansing